Table V.
GABRG2 G>A 3145 and GABRG2 Asn 196 Asn polymorphism by gender
| Patient groups | Gender | Total | ||||
|---|---|---|---|---|---|---|
| Female | Male | |||||
| Cases (groups 1 and 2) p = 0.001 |
GABRG2 INTRON | AA | N (%) | 8 (26.7) | 19 (63.3) | 27 (45.0) |
| AG | N (%) | 9 (30.0) | 7 (23.3) | 16 (26.7) | ||
| GG | N (%) | 13 (43.3) | 4 (13.3) | 17 (28.3) | ||
| Total | N (%) | 30 (100.0) | 30 (100.0) | 60 (100.0) | ||
| Controls p = 0.001 |
GABRG2 INTRON | AA | N (%) | 27 (30.0) | 11 (17.5) | 38 (24.8) |
| AG | N (%) | 34 (37.8) | 44 (69.8) | 78 (51.0) | ||
| GG | N (%) | 29 (32.2) | 8 (12.7) | 37 (24.2) | ||
| Total | N (%) | 90 (100.0) | 63 (100.0) | 153 (100.0) | ||
| Cases (groups 1 and 2) p = 0.052 |
GABRG2 Asn 196 Asn | CC | N (%) | 11 (36.7) | 20 (66.7) | 31 (51.7) |
| CT | N (%) | 15 (50.0) | 9 (30.0) | 24 (40.0) | ||
| TT | N (%) | 4 (13.3) | 1 (3.3) | 5 (8.3) | ||
| Total | N (%) | 30 (100.0) | 30 (100.0) | 60 (100.0) | ||
| Controls p = 0.07 |
GABRG2 Asn 196 Asn | CC | N (%) | 39 (43.3) | 40 (63.5) | 79 (51.6) |
| CT | N (%) | 38 (42.2) | 19 (30.2) | 57 (37.3) | ||
| TT | N (%) | 13 (14.4) | 4 (6.3) | 17 (11.1) | ||
| Total | N (%) | 90 (100.0) | 63 (100.0) | 153 (100.0) | ||